Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NNC-45-0781, a promising candidate for postmenopausal osteoporosis

Feb. 5, 2002

New compounds identified at City of Hope to inhibit the glycation of proteins

Feb. 4, 2002

Amgen's Neulasta approved for febrile neutropenia

Feb. 4, 2002

Approvable letter received for use of Altocor in hypercholesterolemia

Feb. 4, 2002

Quintiles and Kos sign commercialization agreement for Advicor and Niaspan

Feb. 4, 2002

First metabolic drug targets screened in Bayer/CuraGen alliance

Feb. 4, 2002

Aromatic carboxamides effective as orexin-1 receptor antagonists

Feb. 1, 2002

Optimal glycemic control obtained on mealtime repaglinide

Feb. 1, 2002

Two series of HMG-CoA reductase inhibitors with utility in lipid metabolism disorders

Jan. 31, 2002

Sanofi-Synthelabo identifies new series of beta3-adrenoceptor agonists

Jan. 31, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...